Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOXORUBICIN vs DOXYLAMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOXORUBICIN vs DOXYLAMINE: Safety Overview

Metric DOXORUBICIN DOXYLAMINE
Total FAERS Reports 82,754 4,401
Deaths Reported 15,653 1,161
Death Rate 18.9% 26.4%
Hospitalizations 28,630 619
Average Patient Age 50.5 yrs 44.6 yrs
% Female Patients 53.9% 62.4%
FDA Approval Date Approved Prior to Jan 1, 1982 Approved Prior to Jan 1, 1982
Manufacturer Hikma Pharmaceuticals USA Inc. American Sales Company
Route INTRAVENOUS ORAL
Marketing Status Discontinued Discontinued